Development of tetravalent synthetic peptide dengue vaccine using nanoparticle as vaccine delivery vehicle
Dengue is a major public health problem that caused an estimated 390 million infections annually, of which 96 million are symptomatic. Vaccination remains as the major approach in prevention and control of dengue. Only one dengue vaccine [liveattenuated vaccine (LAV), Dengvaxia®] has been licensed f...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Published: |
2023
|
| Subjects: | |
| Online Access: | http://eprints.sunway.edu.my/2418/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|